This diagnostic instrument is a fast in vitro check meant for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, Influenza A, and Influenza B in nasal swab specimens obtained from people suspected of respiratory viral an infection in step with COVID-19 by their healthcare supplier. The assay makes use of real-time reverse transcription polymerase chain response (RT-PCR) expertise.
Simultaneous detection of those three respiratory viruses is essential for environment friendly affected person administration, particularly throughout peak flu seasons the place signs usually overlap. This method reduces the necessity for a number of checks, saving time and sources whereas permitting healthcare professionals to rapidly decide the suitable course of remedy, whether or not that be supportive take care of influenza or particular antiviral therapies and isolation protocols for SARS-CoV-2.
